Results 151 to 160 of about 17,594 (242)

Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease. [PDF]

Protein Sci
Skrehot JT, Kurouski D.
europepmc   +1 more source

Digital assets: risks, regulations, mitigation. [PDF]

Financ Innov
Teng HW, Härdle WK, Osterrieder J, Pele DT, Baals LJ, Papavassiliou V, Bolesta K, Kabašinskas A, Filipovska O, Thomaidis NS, Moukas AI, Goundar S, Nasir JA, Weinberg AI, Arakelian V, Truică CO, Akar M, Kabaklarlı E, Apostol ES, Iannario M, Bȩdowska-Sójka B, Skaftadóttir HK, Yildirim O, Shala A, Pisoni G, Coita IF, Korba S, Hafner CM, Schwendner P, Molnár B, Xhumari E.   +30 more
europepmc   +1 more source

Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer's pathology. [PDF]

Acta Neuropathol
Le LTHL, Lee G, Shin JW, Shim YM, Kim SI, Park SH, Won JK, Lee MJ.   +7 more
europepmc   +1 more source

The Determinant of Tau Spreading in Alzheimer's Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity? [PDF]

Int J Mol Sci
Riku Y, Brion JP, Ando K, Uchihara T, Iwasaki Y.   +4 more
europepmc   +1 more source

Region-specific ups and downs in mitochondrial numerical densities during Alzheimer's disease progression: A pilot study in human brains. [PDF]

J Alzheimers Dis
Balsliemke AL, Ahlemeyer B, Schmidl E, Acker T, Schänzer A, Baumgart-Vogt E.   +5 more
europepmc   +1 more source

Price prediction of PFP NFT based on the sentiments of users in posts on social media. [PDF]

Sci Rep
Jang S, Lee D.
europepmc   +1 more source

AI guided discovery of a murine model of asymptomatic Alzheimer's disease. [PDF]

Acta Neuropathol Commun
Jati S, Taheri S, Kal S, Sinha SC, Head BP, Mahata SK, Sahoo D.   +6 more
europepmc   +1 more source

Cerebellar oligodendrocytic α-synuclein pathology and dentate nucleus neuronal hypertrophy in Parkinson's disease. [PDF]

Sci Rep
Iacono D, Peng H, Bouffard JP, Kurlan R.
europepmc   +1 more source

NON-FUNGIBLE TOKENS (NFTS) AND COPYRIGHT LAW

The concept of using non-fungible tokens (NFTs) to facilitate and authenticate sales of digital art dates back to 2014; but it took several years before the concept really captured public attention.
Ochoa, Tyler T.
core   +2 more sources

Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease. [PDF]

Alzheimers Dement
Bouchoucha K, Collin L, Coquette C, Colmant L, Boyer E, Huyghe L, Quenon L, Gerard T, Salman Y, Hox V, Kienlen-Campard P, Hanseeuw B, Decottignies A, Huart C.   +13 more
europepmc   +1 more source